These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35757709)

  • 1. Single-Cell Landscape of Mouse Islet Allograft and Syngeneic Graft.
    Chen P; Yao F; Lu Y; Peng Y; Zhu S; Deng J; Wu Z; Chen J; Deng K; Li Q; Pu Z; Mou L
    Front Immunol; 2022; 13():853349. PubMed ID: 35757709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo.
    Kupfer TM; Crawford ML; Pham K; Gill RG
    J Immunol; 2005 Aug; 175(4):2309-16. PubMed ID: 16081800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
    Wang XY; Sun J; Wang C; France M; Sheil AG
    Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet allograft rejection is independent of toll-like receptor signaling in mice.
    Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
    Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice.
    Makhlouf L; Yamada A; Ito T; Abdi R; Ansari MJ; Khuong CQ; Winn HJ; Auchincloss H; Sayegh MH
    J Am Soc Nephrol; 2003 Aug; 14(8):2168-75. PubMed ID: 12874472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts.
    Hughes AD; Zhao D; Dai H; Abou-Daya KI; Tieu R; Rammal R; Williams AL; Landsittel DP; Shlomchik WD; Morelli AE; Oberbarnscheidt MH; Lakkis FG
    J Clin Invest; 2020 Jan; 130(1):287-294. PubMed ID: 31763998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to antigen-presenting cell-depleted islet allografts is CD4 T cell dependent.
    Coulombe M; Yang H; Wolf LA; Gill RG
    J Immunol; 1999 Mar; 162(5):2503-10. PubMed ID: 10072489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
    Beilke J; Johnson Z; Kuhl N; Gill RG
    Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
    Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
    Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
    Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
    Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
    Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
    Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
    Barbara JA; Turvey SE; Kingsley CI; Spriewald BM; Hara M; Witzke O; Morris PJ; Wood KJ
    Transplantation; 2000 Dec; 70(11):1641-9. PubMed ID: 11152227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An essential contribution by IFN-gamma to CD8+ T cell-mediated rejection of pancreatic islet allografts.
    Diamond AS; Gill RG
    J Immunol; 2000 Jul; 165(1):247-55. PubMed ID: 10861058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local expression of indoleamine 2,3 dioxygenase in syngeneic fibroblasts significantly prolongs survival of an engineered three-dimensional islet allograft.
    Jalili RB; Forouzandeh F; Rezakhanlou AM; Hartwell R; Medina A; Warnock GL; Larijani B; Ghahary A
    Diabetes; 2010 Sep; 59(9):2219-27. PubMed ID: 20522587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
    Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
    Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice.
    Lee MK; Huang X; Jarrett BP; Moore DJ; Desai NM; Moh Lian M; Markmann JW; Deng S; Frank A; Singer A; Velidedeoglu E; Caton AJ; Markmann AJ
    Transplantation; 2003 Apr; 75(8):1415-22. PubMed ID: 12717241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade.
    Makhlouf L; Kishimoto K; Smith RN; Abdi R; Koulmanda M; Winn HJ; Auchincloss H; Sayegh MH
    Diabetes; 2002 Nov; 51(11):3202-10. PubMed ID: 12401711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.